Inhibition of aryl hydrocarbon receptor signaling promotes the terminal differentiation of human erythroblasts. (11th January 2022)
- Record Type:
- Journal Article
- Title:
- Inhibition of aryl hydrocarbon receptor signaling promotes the terminal differentiation of human erythroblasts. (11th January 2022)
- Main Title:
- Inhibition of aryl hydrocarbon receptor signaling promotes the terminal differentiation of human erythroblasts
- Authors:
- Chen, Yijin
Dong, Yong
Lu, Xulin
Li, Wanjing
Zhang, Yimeng
Mao, Bin
Pan, Xu
Li, Xiaohong
Zhou, Ya
An, Quanming
Xie, Fangxin
Wang, Shihui
Xue, Yuan
Cai, Xinping
Lai, Mowen
Zhou, Qiongxiu
Yan, Yan
Fu, Ruohan
Wang, Hong
Nakahata, Tatsutoshi
An, Xiuli
Shi, Lihong
Zhang, Yonggang
Ma, Feng - Editors:
- Meng, Anming
- Abstract:
- Abstract: The aryl hydrocarbon receptor (AHR) plays an important role during mammalian embryo development. Inhibition of AHR signaling promotes the development of hematopoietic stem/progenitor cells. AHR also regulates the functional maturation of blood cells, such as T cells and megakaryocytes. However, little is known about the role of AHR modulation during the development of erythroid cells. In this study, we used the AHR antagonist StemRegenin 1 (SR1) and the AHR agonist 2, 3, 7, 8-tetrachlorodibenzo- p -dioxin during different stages of human erythropoiesis to elucidate the function of AHR. We found that antagonizing AHR signaling improved the production of human embryonic stem cell derived erythrocytes and enhanced erythroid terminal differentiation. RNA sequencing showed that SR1 treatment of proerythroblasts upregulated the expression of erythrocyte differentiation-related genes and downregulated actin organization-associated genes. We found that SR1 accelerated F-actin remodeling in terminally differentiated erythrocytes, favoring their maturation of the cytoskeleton and enucleation. We demonstrated that the effects of AHR inhibition on erythroid maturation were associated with F-actin remodeling. Our findings help uncover the mechanism for AHR-mediated human erythroid cell differentiation. We also provide a new approach toward the large-scale production of functionally mature human pluripotent stem cell-derived erythrocytes for use in translational applications.
- Is Part Of:
- Journal of molecular cell biology. Volume 14:Number 2(2022)
- Journal:
- Journal of molecular cell biology
- Issue:
- Volume 14:Number 2(2022)
- Issue Display:
- Volume 14, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 14
- Issue:
- 2
- Issue Sort Value:
- 2022-0014-0002-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-01-11
- Subjects:
- erythroblast -- AHR -- SR-1 -- human pluripotent stem cells -- differentiation
Molecular biology -- Periodicals
571.605 - Journal URLs:
- http://jmcb.oxfordjournals.org/ ↗
http://ukcatalogue.oup.com/ ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=120338 ↗ - DOI:
- 10.1093/jmcb/mjac001 ↗
- Languages:
- English
- ISSNs:
- 1674-2788
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5020.705065
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21533.xml